Pfizer Significantly Increases Oncology Presence with Medivation Acquisition

By Dan Roberts

Pharma Deals Review: Vol 2016 Issue 8 (Table of Contents)

Published: 26 Aug-2016

DOI: 10.3833/pdr.v2016.i8.2185     ISSN: 1756-7874

Section: Mergers & Acquisitions



Pfizer and Medivation have announced that they have entered into a definite merger agreement, whereby Pfizer will acquire Medivation for US$81...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details